Please provide your email address to receive an email when new articles are posted on . AL001 is designed to target lithium delivery in the brain, mitigating toxicity in other organs. The drug will be ...

Lithium-a decades-old treatment for bipolar disorder-may hold potential neuroprotective benefits beyond mood stabilization.An ...

A multicenter study of young patients with bipolar disorder provides what may be the most scientifically rigorous demonstration to date that lithium -- a drug used successfully for decades to treat ...

A pilot clinical trial has found that low-dose lithium tablets might help slow verbal decline among seniors with mild ...

ATLANTA--(BUSINESS WIRE)--Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for ...

Lithium has long been described as the "penicillin of psychiatry" and the "gold standard" in the treatment of bipolar disorder, yet its use in the United States has decreased steadily in the past 25 ...

A clinical trial suggests that low-dose lithium may slow the decline of verbal memory in older adults with mild cognitive impairment and amyloid-beta.

For decades, patients with bipolar disorder have had to rely on frequent blood tests to ensure their lithium medication is working safely. Now, a groundbreaking study published in Device has unveiled ...

Changes Clinical Practice: Based on this large trial, lithium alone or a lithium-valproate combination should be used as first-line maintenance treatment for bipolar affective disorder type I instead ...

LONDON (Reuters) - A drug for bipolar disorder that works like lithium - the most common and effective treatment - but without lithium's side-effects has been identified by British researchers in ...